Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Debt Ratio (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Debt Ratio for 3 consecutive years, with 0.03 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.03 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.03, a N/A change, with the full-year FY2022 number at 0.02, changed N/A from a year prior.
  • Debt Ratio was 0.03 for Q3 2025 at Century Therapeutics, up from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.03 in Q3 2025 to a low of 0.02 in Q1 2022.
  • A 3-year average of 0.02 and a median of 0.02 in 2022 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 23.98% in 2023; the steepest drop was 23.98% in 2023.
  • Century Therapeutics' Debt Ratio stood at 0.02 in 2022, then grew by 7.23% to 0.02 in 2023, then surged by 50.96% to 0.03 in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Debt Ratio are 0.03 (Q3 2025), 0.02 (Q1 2023), and 0.02 (Q4 2022).